Improving biologicals

MicroIN is a biotechnology platform that enables biological innovations—particularly microorganisms—to become viable, scalable, and effective commercial products. Through advanced encapsulation and formulation technologies, MicroIN addresses a key bottleneck in the biologics industry: the difficulty of translating promising biological agents into stable, field-ready solutions.

Despite decades of research, less than 10% of studied microorganisms reach the market. The main limitation is not discovery, but formulation—most biologicals are too fragile to withstand storage, transport, and real-world environmental conditions. This creates a massive untapped opportunity to unlock the remaining biological potential.

MicroIN tackles this challenge through a proprietary, configuration-driven platform that combines bioinspired microencapsulation, controlled release systems, and data-driven formulation design. By developing tailored matrices adapted to each microorganism and application, MicroIN significantly improves stability, viability, and performance while eliminating cold chain dependency and reducing operational costs.

Operating as a Biotech-as-a-Service (BaaS), MicroIN partners with companies to develop customized formulations, supporting them from early-stage development through greenhouse validation and delivering protocols ready for field trials and regulatory processes.

To date, MicroIN has demonstrated up to 50% improvement in microbial viability during storage and in soil, and up to 20% increased tolerance to environmental stress and contaminants. The company is currently advancing industrial pilots with partners across Latin America.

MicroIN is now expanding collaborations with biological product developers and agro-industrial companies to scale validation, accelerate time-to-market, and establish long-term commercial partnerships.